Is this you? Create Your Porfile
Avatar

Antje Schulze

Leipzig University

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Antje Schulze is active.

Explore More

Publication

Featured researches published by Antje Schulze.

Blood | 2014

Higher Leukemia Free Survival after Post-Induction Hematopoietic Cell Transplantation Compared to Consolidation Therapy in Patients >60 Years with Acute Myelogenous Leukemia (AML): Report from the AML 2004 East German Study Group (OSHO)

Dietger Niederwieser; Haifa Kathrin Al-Ali; Rainer Krahl; Christoph Kahl; Hans-Heinrich Wolf; Ute Kreibich; Vladan Vucinic; Detlev Haehling; Ute Hegenbart; Alwin Kraemer; Carsten Hirt; Norma Peter; Bernhard Opitz; Axel Florschütz; Kolja Reifenrath; Antje Schulze; Niklas Zojer; Sebastian Scholl; Christian Jakob; Christian Junghanss; Wolfram Pönisch; Simone Heyn; Herbert G. Sayer; Andreas Hochhaus; Thomas Heinicke; Thomas Fischer; Georg Maschmeyer; Peter Dreger

Blood | 2016

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Dietger Niederwieser; Verena S. Hoffmann; Markus Pfirrmann; Haifa Kathrin Al-Ali; Sebastian Schwind; Vladan Vucinic; Rainer Krahl; Christoph Kahl; Hans-Heinrich Wolf; Ute Kreibich; Detlef Hähling; Ute Hegenbart; Carsten Hirt; Norma Peter; Axel Florschuetz; Kolja Reifenrath; Antje Schulze; Niklas Zojer; Sebastian Scholl; Christian Junghanss; Wolfram Pönisch; Simone Heyn; Herbert G. Sayer; Andreas Hochhaus; Thomas Heinicke; Thomas Fischer; Alwin Krämer; Peter Dreger; Georg Maschmeyer; Utz Krug

Journal of Clinical Oncology | 2016

Hematopoietic stem cell transplantation (HSCT) compared to consolidation chemotherapy (CT) to increase leukemia free survival (LFS) in acute myelogenous leukemia (AML) patients between 60 and 75 years irrespective of genetic risk: Report from the AML 2004 of the East German Study Group (OSHO).

Dietger Niederwieser; Haifa Kathrin Al-Ali; Rainer Krahl; Christoph Kahl; Hans-Heinrich Wolf; Ute Kreibich; Vladan Vucinic; Ute Hegenbart; Carsten Hirt; Norma Peter; Bernhard Opitz; Axel Florschütz; Antje Schulze; Sebastian Scholl; Christian Jakob; Christian Junghanss; Herbert G. Sayer; Andreas Hochhaus; Thomas Fischer; Georg Maschmeyer

Blood | 2013

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Rainer Krahl; Christian Jakob; Thomas Heinicke; Christoph Kahl; Antje Schulze; Hans-Heinrich Wolf; Bernhard Opitz; Ute Kreibich; Frank Rothmann; Christian Junghanss; Detlev Haehling; Manfred Schulze; Norma Peter; Ute Hegenbart; Haifa Kathrin Al-Ali; Carsten Hirt; Wolfram Poenisch; Thoralf Lange; Simone Heyn; Vladan Vucinic; Kristina Bartsch; Thomas Fischer; Georg Maschmeyer; Andreas Hochhaus

Blood | 2007

High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).

Cornelia Becker; R. Krahl; H.K. Al Ali; Wolfram Poenisch; Michael Cross; Simone Heyn; Anke Gerhardt; Antje Schulze; U. Mahlknecht; Detlev Haehling; Manfred Schulze; Matthias Freund; Erika Kettner; Gottfried Doelken; Heiner Wolf; Ernst Zschuppe; Norma Peter; Andre Franke; Ulrich Wedding; Lutz Uharek; Ute Kreibich; Axel Florschuetz; Bernhard Opitz; N. Zojer; Werner Helbig; Dietger Niederwieser

Blood | 2006

Increased Leukaemia Free Survival (LFS) in Patients with Cytogenetic High Risk AML after Related or Unrelated Hematopoietic Cell Transplantation (HCT) Compared to Chemotherapy in the OSHO 96 and 2002 Studies.

Dietger Niederwieser; Cornelia Becker; Rainer Krahl; Haifa-Kathrin Al-Ali; Simone Heyn; Michael Cross; Thoralf Lange; Anke Gerhardt; Antje Schulze; Detleff Haehling; Manfred Schulze; Matthias Freund; Erika Kettner; Gottfried Dölken; Michael Assmann; Hans-Heinrich Wolf; Ernst Zschuppe; Norma Peter; Astrid Franke; Ulrich Wedding; Lutz Uharek; Ute Kreibich; Norbert Grobe; Thomas Ittel; Axel Florschuetz; Bernd Opitz; Karin Senftleben; Veronika Schirmer; Friedrich Fiedler; Renate Huhn

Blood | 2015

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Dietger Niederwieser; Verena S. Hoffmann; Utz Krug; Rainer Krahl; Christina Sauerland; Karsten Spiekermann; Stefan K. Bohlander; Ute Hegenbart; Wolfram Poenisch; Vladan Vucinic; Michael Cross; Nadja Jaekel; Markus Pfirrmann; Antje Schulze; Alwin Kraemer; Georg Maschmeyer; Christian Junghanss; Sebastian Scholl; Christian Jakob; Thomas Heinicke; Detlev Haehling; Norma Peter; Ute Kreibich; Christoph Busemann; Haifa Kathrin Al-Ali; Ahmet H. Elmaagacli; Bernhard Opitz; Hans-Heinrich Wolf; Wolfgang Hiddemann; Wolfgang E. Berdel

Blood | 2014

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Christoph Kahl; Rainer Krahl; Haifa Kathrin Al-Ali; Herbert G. Sayer; Antje Schulze; Michael Herold; Mathias Hänel; Sebastian Scholl; Andreas Hochhaus; Lutz Uharek; Georg Maschmeyer; Detlev Hähling; Christian Junghanss; Norma Peter; Dietrich Kämpfe; Erika Kettner; Thomas Heinicke; Thomas Fischer; Ute Kreibich; Hans-Heinrich Wolf; Dietger Niederwieser

Blood | 2013

Prognostic Factors For Overall Survival In Elderly Patients With Relapsed Acute Myeloid Leukemia – Retrospective Study On Behalf Of The East German Study Group For Hematology and Oncology (OSHO)

Rainer Krahl; Christian Jakob; Christoph Kahl; Hans-Heinrich Wolf; Ute Kreibich; Frank Rothmann; Detlev Hähling; Manfred Schulze; Ulrich Wedding; Ute Hegenbart; Carsten Hirt; Norma Peter; Bernhard Opitz; Antje Schulze; Christian Junghanss; Andreas Hochhaus; Thomas Fischer; Dietger Niederwieser; Haifa Kathrin Al-Ali

Blood | 2008

Ten Year Follow up Analysis of the OSHO Phase III Trial (AML 96) Comparing Different Application Modes of AraC in Patients below 60 Years with Acute Myeloid Leukemia (AML): No Impact of AraCApplication Mode on Remission Rate, Toxicity, Disease-Free Survival or Overall Survival

Cornelia Becker; Rainer Krahl; Antje Schulze; Georg Maschmeyer; Christian Junghanß; Astrid Franke; Norma Peter; Mathias Haenel; Ulrich Wedding; Hans-Heinrich Wolf; Detlev Haehling; Johannes Meran; Gottfried Doelken; Dietrich Kaempfe; Erika Kettner; Norbert Grobe; Axel Florschuetz; Ute Kreibich; Veronika Schirmer; Thomas Ittel; Mathias Schulze; Renate Huhn; Ernst Zschuppe; Bernd Opitz; Michael Assmann; Dirk Hasenclever; Wolfram Poenisch; Werner Helbig; Dietger Niederwieser

Explore More

Collaboration

Dive into the Antje Schulze's collaboration.

Top Co-Authors
Avatar

Norma Peter

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Rainer Krahl

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Dietger Niederwieser

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Ute Kreibich

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Haifa Kathrin Al-Ali

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Bernhard Opitz

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Georg Maschmeyer

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Andreas Hochhaus

University of Jena

View shared research outputs
Top Co-Authors
Avatar

Detlev Haehling

Leipzig University

View shared research outputs
Top Co-Authors
Avatar

Simone Heyn

Leipzig University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge